Home>Topics>Companies>Sanofi S.A.

Sanofi S.A.

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Three months on, fruitless CEO search overshadows Sanofi

    Headlines

    Fri, 30 Jan 2015

    PARIS (Reuters) - Barring a last-minute breakthrough, drugs firm Sanofi 's Chairman Serge Weinberg may have to acknowledge in his results presentation next week that the hunt for a new chief executive is not going well.

  2. Three months on, fruitless CEO search overshadows Sanofi

    Headlines

    Fri, 30 Jan 2015

    PARIS, Jan 30 (Reuters) - Barring a last-minute breakthrough, drugs firm Sanofi 's Chairman Serge Weinberg may have to acknowledge in his results presentation next week that the hunt for a new chief executive is not going well.

  3. Ousted Sanofi CEO gets 4.44 million euro severance package

    Headlines

    Thu, 22 Jan 2015

    PARIS (Reuters) - European pharmaceuticals group Sanofi on Thursday said it had agreed to pay 4.44 million euros ($5.06 million) in total to ousted chief executive Chris Viehbacher .

  4. UPDATE 1-Ousted Sanofi CEO gets 4.44 mln eur severance package

    Headlines

    Thu, 22 Jan 2015

    PARIS, Jan 22 (Reuters) - European pharmaceuticals group Sanofi on Thursday said it had agreed to pay 4.44 million euros ($5.06 million) in total to ousted chief executive Chris Viehbacher .

  5. UPDATE 2- Sanofi , Regeneron cholesterol drug also effective in monthly doses

    Headlines

    Fri, 9 Jan 2015

    Jan 9 (Reuters) - An experimental drug from Sanofi SA and Regeneron Pharmaceuticals was found to be effective in lowering "bad" cholesterol even when administered once every four weeks, instead of every two weeks.

  6. 5 Wide-Moat Stocks That Were Left Behind in 2014

    Video Reports

    Fri, 2 Jan 2015

    care stock did well, including wide-moat [TICKER: SNY ] Sanofi . Glaser: Health-care stocks looked very strong in 2014, driven partially by an M&A boom. But [TICKER: SNY ] Sanofi looked a lot weaker, and there are a few things happening

    SNY Sanofi found at 5:02, 6:07

    health care in 2014, but not every health-care stock did well, including wide-moat [TICKER: SNY ] Sanofi . Glaser: Health-care stocks looked very strong in 2014, driven partially by an M&A boom. But [TICKER: SNY ] Sanofi looked a lot weaker, and there are a few things happening here. One were fundamental concerns about the business. Questions about what's
    able to actually reap those cash flows. We saw this stewardship hiccup at [TICKER: SNY ] Sanofi , and investors weren't happy about that. I think this highlights the importance of making sure that strong stewardship is there instead of
  7. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

    Video Reports

    Fri, 2 Jan 2015

    year's ranking, the top two firms were [TICKER: SNY ] Sanofi ( SNY ) and Merck (MRK). And just taking those one at ..... incident rate cancers like lung cancer. [TICKER: SNY ] Sanofi is a firm where the pipeline is not as strong as Merck

    SNY Sanofi found at 1:30, 2:12, 3:51

    ranking and why? Conover: In this year's ranking, the top two firms were [TICKER: SNY ] Sanofi SNY and Merck (MRK). And just taking those one at a time: Merck's a firm that is really in this transitionary period of
    shift in how we treat very large incident rate cancers like lung cancer. [TICKER: SNY ] Sanofi is a firm where the pipeline is not as strong as Merck, but it's a firm that doesn't have a lot of
    having me. Coffina: In conclusion, in this year's Big Pharma ranking, Merck and [TICKER: SNY ] Sanofi came out on top--Merck because of its very strong pipeline and [TICKER: SNY ] Sanofi mostly because of its lack of patent losses over the next five years. On the other end of the spectrum, Pfizer and [TICKER:GSK]
  8. Health Care: A Strong Run, but Some Stocks Still Look Undervalued

    Headlines

    Wed, 31 Dec 2014

    Wide Medium SEK 65.50 Sanofi $59 Wide Medium $41 ..... positioned for growth. Sanofi SNY Despite some weakness in ..... insulin drugs, we expect Sanofi 's key narrow- and wide ..... community underappreciates Sanofi 's strong competitive advantages

  9. TRLPC- Sanofi agrees 8 bln euro loan refinancing

    Headlines

    Wed, 17 Dec 2014

    LONDON, Dec 17 (Reuters) - French drugmaker Sanofi has completed an 8 billion euro refinancing of its two syndicated revolving credit facilities, the company said in an email on Wednesday.

  10. Bayer to sell equine assets to Sanofi unit

    Headlines

    Wed, 17 Dec 2014

    FRANKFURT, Dec 17 (Reuters) - German drugmaker Bayer said on Wednesday it had entered into a definitive agreement to sell veterinary products to treat horses to Sanofi 's animal health unit Merial.

« Prev12345Next »
Content Partners